Reuters logo
BRIEF-Pharming Group announces positive data from paediatric clinical trial of Ruconest
October 2, 2017 / 5:18 AM / 2 months ago

BRIEF-Pharming Group announces positive data from paediatric clinical trial of Ruconest

Oct 2 (Reuters) - PHARMING GROUP NV:

* PHARMING ANNOUNCES POSITIVE DATA FROM PAEDIATRIC CLINICAL TRIAL WITH RUCONEST®

* ‍MEDIAN TIME TO ONSET OF RELIEF WAS 60 MINUTES​

* ‍MEDIAN TIME TO MINIMAL SYMPTOMS WAS 122 MINUTES​

* ‍ONLY 3/73 (4%) ATTACKS WERE TREATED WITH A SECOND DOSE OF RUCONEST®.​

* ‍RUCONEST® WAS GENERALLY SAFE AND WELL-TOLERATED IN STUDY​

* ‍NO PATIENTS WITHDREW FROM STUDY DUE TO ADVERSE EVENTS.​

* ‍STUDY REPORTED CLINICALLY MEANINGFUL RELIEF OF SYMPTOMS​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below